Article citationsMore >>

Zangari M1, Siegel E, Barlogie B, Anaissie E, Saghafifar F, Fassas A, Morris C, Fink L, Tricot G.Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy. Blood. 2002 Aug 15; 100(4):1168-71.

has been cited by the following article:

Article

Pulmonary Embolism: A Rare Initial Manifestation of Multiple Myeloma

1Department of Internal Medicine, St. Michael’s Medical Center, Newark, USA

2Department of Hematology and Oncology, St. Joseph’s Regional Medical Center, New Jersey, USA

3Department of Internal Medicine, St. Joseph’s Regional Medical Center, New Jersey, USA

4Department of Pulmonary Medicine, St. Michael’s Medical Center, Newark, USA


American Journal of Medical Case Reports. 2015, Vol. 3 No. 8, 244-246
DOI: 10.12691/ajmcr-3-8-6
Copyright © 2015 Science and Education Publishing

Cite this paper:
Parijat Sen, Abhishek Kumar, Mary Mathews, Daphne Macbruce, Richard Miller. Pulmonary Embolism: A Rare Initial Manifestation of Multiple Myeloma. American Journal of Medical Case Reports. 2015; 3(8):244-246. doi: 10.12691/ajmcr-3-8-6.

Correspondence to: Mary  Mathews, Department of Internal Medicine, St. Joseph’s Regional Medical Center, New Jersey, USA. Email: mary.mathews@live.ca

Abstract

Multiple Myeloma usually presents with end organ damage like bone symptoms such as pain, pathologic fracture, renal dysfunction, chronic fatigue from anemia or symptoms of hypercalcemia. Although frequently associated with venous thromboembolisms, the presentation of multiple myeloma with pulmonary embolism as its initial manifestation is extremely rare. We report the case of a 60 y/o Hispanic male who presented with a Pulmonary Embolism, further diagnostic test revealed an underlying diagnosis of Multiple Myeloma.

Keywords